Optison vial 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AW8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,032
Award facts
- Contract value 100% obligated
- $2,031.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,031.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Optison vials (3 mL). The order is not set-aside and carries an ultimate completion date of February 20, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is issued under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which functions as a comprehensive global pharmaceutical support vehicle.
The underlying IDC with DLA enables AmerisourceBergen to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits—to support military healthcare programs worldwide. Through this contract vehicle, the company serves critical customers including the Defense Health Agency and U.S. Coast Guard. The current task order for Optison, a diagnostic ultrasound contrast agent used in medical imaging, reflects the company's role in fulfilling specialized pharmaceutical procurement needs across the federal medical supply chain. All reviewed contract awards under this relationship have been competitively awarded with firm fixed pricing, demonstrating AmerisourceBergen's capability to meet federal procurement standards through open competition.
Quick answers
Who was awarded contract SPE2DR26F1AW8?
SPE2DR26F1AW8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F1AW8 worth?
The government has obligated $2,032 on SPE2DR26F1AW8.
Is contract SPE2DR26F1AW8 an order under another contract?
Yes. SPE2DR26F1AW8 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AW8 competed?
The extent of competition for SPE2DR26F1AW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award